FDA sends warning letters to eye implant, bone matrix manufacturers

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesCBERCDERComplianceGMPPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited StatesWarning letters